This study may be
We invite those 18 to 60 years old with articular cartilage injury
of the knee to see if they may qualify for the FastTRACK Study.
The purpose of this clinical research study is to evaluate the safety and effectiveness of HYALOFAST®, a one-step procedure to help regrow cartilage. HYALOFAST is not approved for use in the United States; however, it is approved in Europe and has been in use since 2009.
Find a participating doctor
Each individual will be evaluated to determine his or her eligibility. Those who qualify will receive the procedure, study-related medical exams, and post-procedure rehabilitation at no charge.